Vendor, Uppsala, SWE
Uppsala Universitet
UEI KTRDK57SR316, CAGE AM98N
1 award and $0 obligated between September 24, 2024 and September 24, 2024, 100% under full and open competition, against 165.0 offers on average where reported.
Industries
NAICS on the awards, by dollars.
| Research and Development in Biotechnology (except Nanobiotechnology)NAICS 541714 | $0 |
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition | 1 |
| Definitive Contract | 1 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 75F40122C00139Definitive Contract, September 24, 2024, Full and Open Competition, 165 offers | FDA Office of Acq Grant SVCSFood and Drug Administration | No Cost Modification to Change the Period of Performance End Date to March 31, 2025.NAICS 541714, PSC AN11 | $0 |
- Product and service codes
- AN11 Health R&D Services; Health Care Services; Basic Research
- Transactions
- 1 across 1 awards